APA

Delpech Y., Coutant C., Hsu L., Barranger E., Iwamoto T., Barcenas C. H., Hortobagyi G. N., Rouzier R., Esteva F. J. & Pusztai L. (20130402). Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas. : British journal of cancer.

Chicago

Delpech Y, Coutant C, Hsu L, Barranger E, Iwamoto T, Barcenas C H, Hortobagyi G N, Rouzier R, Esteva F J and Pusztai L. 20130402. Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas. : British journal of cancer.

Harvard

Delpech Y., Coutant C., Hsu L., Barranger E., Iwamoto T., Barcenas C. H., Hortobagyi G. N., Rouzier R., Esteva F. J. and Pusztai L. (20130402). Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas. : British journal of cancer.

MLA

Delpech Y, Coutant C, Hsu L, Barranger E, Iwamoto T, Barcenas C H, Hortobagyi G N, Rouzier R, Esteva F J and Pusztai L. Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas. : British journal of cancer. 20130402.